Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription 28.04.2025 1 BMC Pediatr 1 J Immunol 1 J Virol 2 JAMA 1 Lancet 1 MMWR Morb Mortal Wkly Rep 1 N Engl J Med 1 Pediatr Infect Dis J 2 Pediatrics 1 PLoS Comput Biol 1 PLoS One 11 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Pediatr

1. SHOKRI M, Movahedi M, Parvaneh N, Gharagozlou M, et al
   Safety of MMR vaccination evaluated in children with food and gelatin allergy in Iran.
   BMC Pediatr. 2025;25:318.
   PubMed         Abstract available
   
   

   
   J Immunol

2. ZHENG G, Oo TT, Janjam SSS, Ellis C, et al
   An antigen-less pro-vaccine for treating autoimmunity.
   J Immunol. 2025 Apr 24:vkaf068. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

3. LE CTT, Kim K-H, Raha JR, Bhatnagar N, et al
   Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination.
   J Virol. 2025 Apr 23:e0229424. doi: 10.1128/jvi.02294.
   PubMed         Abstract available
   
   

   
   JAMA

4. KIANG MV, Bubar KM, Maldonado Y, Hotez PJ, et al
   Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US.
   JAMA. 2025 Apr 24. doi: 10.1001/jama.2025.6495.
   PubMed         Abstract available
   
   
5. POMIRCHY M, Bommer C, Pradella F, Michalik F, et al
   Herpes Zoster Vaccination and Dementia Occurrence.
   JAMA. 2025 Apr 23:e255013. doi: 10.1001/jama.2025.5013.
   PubMed         Abstract available
   
   

   
   Lancet

6. MARQUES ETA, Burke DS
   Safety and immunogenicity of a virus-like particle Chikungunya virus vaccine.
   Lancet. 2025;405:1314-1315.
   PubMed        
   
   

   
   MMWR Morb Mortal Wkly Rep

7. MATHIS AD, Raines K, Filardo TD, Wiley N, et al
   Measles Update - United States, January 1-April 17, 2025.
   MMWR Morb Mortal Wkly Rep. 2025;74:232-238.
   PubMed         Abstract available
   
   

   
   N Engl J Med

8. JATT LP, Mgodi NM, Buchbinder SP, Gray GE, et al
   An HIV Vaccine in the Era of Twice-Yearly Lenacapavir for PrEP - Essential or Irrelevant?
   N Engl J Med. 2025;392:1561-1563.
   PubMed        
   
   

   
   Pediatr Infect Dis J

9. ARRIETA AC, Osborne S, Grant LR, Gessner BD, et al
   Parapneumonic Empyema Complicating Community-acquired Pneumonia: Etiology in the Era of Pneumococcal Vaccination and Role of Molecular Diagnosis.
   Pediatr Infect Dis J. 2025 Apr 21. doi: 10.1097/INF.0000000000004833.
   PubMed         Abstract available
   
   

   
   Pediatrics

10. BANDELL A, Giles L, Cervelo Bouzo P, Sibbring GC, et al
    Safety of LAIV Vaccination in Asthma or Wheeze: A Systematic Review and GRADE Assessment.
    Pediatrics. 2025 Apr 24:e2024068459. doi: 10.1542/peds.2024-068459.
    PubMed         Abstract available
    
    
11. KUO C
    Vaccines Matter: Measles and Its Complications.
    Pediatrics. 2025 Apr 22. doi: 10.1542/peds.2025-071622.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

12. WANG M, Patsenker J, Li H, Kluger Y, et al
    Supervised fine-tuning of pre-trained antibody language models improves antigen specificity prediction.
    PLoS Comput Biol. 2025;21:e1012153.
    PubMed         Abstract available
    
    

    
    PLoS One

13. MURPHY R, Pomerantz L, Kuruppumullage Don P, Sung Kim J, et al
    Correction: Age and political leaning predict COVID-19 vaccination status at a large, multi-campus, public university in Pennsylvania: A cross-sectional survey.
    PLoS One. 2025;20:e0322942.
    PubMed         Abstract available
    
    

    
    Vaccine

14. HONDA-OKUBO Y, Sakala IG, Li L, Bielefeldt-Ohmann H, et al
    Advax(R)-adjuvanted inactivated influenza vaccine provides accelerated protection of mice via early induction of an influenza-specific IgM response.
    Vaccine. 2025;56:127144.
    PubMed         Abstract available
    
    
15. ZHANG X, Shi H, Ross TM
    Multivalent H3 COBRA-based influenza vaccine elicits enhanced immune response in a pre-immune elderly ferret model.
    Vaccine. 2025;56:127156.
    PubMed         Abstract available
    
    
16. JURADO-MARTIN I, Tomas-Cortazar J, Rezk N, Hou Y, et al
    The novel antigen, lipopolysaccharide export protein LptH, protects mice against Pseudomonas aeruginosa acute pneumonia in monovalent and multivalent vaccines.
    Vaccine. 2025;56:127145.
    PubMed         Abstract available
    
    
17. KAHN R, Moiane B, Lessa FC, Massora S, et al
    Corrigendum to "Nasopharyngeal carriage of Streptococcus pneumoniae among children and their household members in southern Mozambique five years after PCV10 introduction" Vaccine, Volume 47, 15 February 2025, 126,691.
    Vaccine. 2025;56:127124.
    PubMed        
    
    
18. XIA Y, Zhu W, Shi Z, Shen Y, et al
    Herpes zoster vaccination coverage and factors associated among adults aged 40 and older in China: A population-based survey.
    Vaccine. 2025;56:127122.
    PubMed         Abstract available
    
    
19. TAKEUCHI N, Chang B, Ishiwada N, Cho Y, et al
    Nationwide population-based surveillance of invasive pneumococcal disease in children in Japan (2014-2022): Impact of 13-valent pneumococcal conjugate vaccine and COVID-19 pandemic.
    Vaccine. 2025;54:127138.
    PubMed         Abstract available
    
    
20. MANTLO EK, Huang YS
    Knowledge-based mitigation of the environmental risk of Orthoflavivirus live-attenuated vaccines by targeting viral encoded determinants for the mosquito attenuated phenotype.
    Vaccine. 2025;54:127114.
    PubMed         Abstract available
    
    
21. FERRERAS-COLINO E, de la Fuente J, Couto J, Golovchenko M, et al
    Immunostimulant effect of heat-inactivated Mycobacterium bovis in mice challenged with vector-borne pathogens.
    Vaccine. 2025;53:127076.
    PubMed         Abstract available
    
    
22. LUN J, Zheng P, Liang X, Hu Y, et al
    Identification of a conserved cryptic epitope with cross-immunoreactivity in outer membrane protein K (OmpK) from Vibrio species.
    Vaccine. 2025;53:126964.
    PubMed         Abstract available
    
    
23. MCGRATH LJ, Khan FL, Lopez SMC, Brouillette MA, et al
    2023-2024 COVID-19 vaccine uptake among immunocompromised individuals in two US states.
    Vaccine. 2025;56:127120.
    PubMed         Abstract available
    
    
24. LUKA MM, Ferguson EA, Rees E, Hoffu H, et al
    Optimising human rabies vaccine supply chains: A modelling study.
    Vaccine. 2025 Apr 21:127108. doi: 10.1016/j.vaccine.2025.127108.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.